Continuous Infusion May Improve the Efficacy of Vancomycin in Treatment of Experimental Endocarditis Due to Heterogeneous Vancomycin-Intermediate Staphylococcus aureus

Gelijkaardige items

• Failure of Vancomycin Continuous Infusion against Experimental Endocarditis Due to Vancomycin-Intermediate Staphylococcus aureus
  door: Entenza, J. M., et al.
  Gepubliceerd in: (2011)
• Vancomycin Treatment Failure Associated with Heterogeneous Vancomycin-Intermediate Staphylococcus aureus in a Patient with Endocarditis and in the Rabbit Model of Endocarditis
  door: Moore, Matthew R., et al.
  Gepubliceerd in: (2003)
• Dosing Nomograms for Attaining Optimum Concentrations of Meropenem by Continuous Infusion in Critically Ill Patients with Severe Gram-Negative Infections: a Pharmacokinetics/Pharmacodynamics-Based Approach
  door: Pea, Federico, et al.
  Gepubliceerd in: (2012)
• Selection of Heterogeneous Vancomycin-Intermediate Staphylococcus aureus by Imipenem
  door: Katayama, Yuki, et al.
  Gepubliceerd in: (2009)
• Pharmacokinetics and Pharmacodynamics of Continuous-Infusion Meropenem in Pediatric Hematopoietic Stem Cell Transplant Patients
  door: Cojutti, Piergiorgio, et al.
  Gepubliceerd in: (2015)